Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CASC4 anticorps (C-Term)

Cet anticorps Lapin Polyclonal détecte spécifiquement CASC4 dans WB et EIA. Il présente une réactivité envers Humain et Souris.
N° du produit ABIN951049

Aperçu rapide pour CASC4 anticorps (C-Term) (ABIN951049)

Antigène

Voir toutes CASC4 Anticorps
CASC4 (Cancer Susceptibility Candidate 4 (CASC4))

Reactivité

  • 13
  • 10
  • 2
  • 2
  • 1
  • 1
  • 1
Humain, Souris

Hôte

  • 13
Lapin

Clonalité

  • 13
Polyclonal

Conjugué

  • 8
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CASC4 est non-conjugé

Application

  • 13
  • 10
  • 7
  • 2
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Épitope

    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 343-373, C-Term

    Specificité

    This antibody reacts to CASC4.

    Réactivité croisée (Details)

    Species reactivity (tested):Human and Mouse.

    Purification

    Affinity chromatography on Protein A

    Immunogène

    KLH conjugated synthetic peptide between 343-373 amino acids from the C-terminal region of human CASC4

    Isotype

    Ig Fraction
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.25 mg/mL

    Buffer

    PBS, 0.09 % (W/V) sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène

    CASC4 (Cancer Susceptibility Candidate 4 (CASC4))

    Autre désignation

    CASC4

    Sujet

    The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30 % of human breast and 20 % of human ovarian cancers. Further characterization of the product of this gene may yield insight into the fundamental biology and pathogenetic effects of HER-2/neu overexpression in human breast and ovarian cancer cells. Alternatively spliced variants encoding different isoforms have been identified for this gene.Synonyms: Cancer susceptibility candidate gene 4 protein

    Poids moléculaire

    48864 Da

    ID gène

    113201

    NCBI Accession

    NP_612432
Vous êtes ici:
Chat with us!